Xing-chen Peng

1 article listing Xing-chen Peng in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial Nature Communications